A researchers survey in the September 20 issue of the Journal of the National Cancer Institute.

The authors found that third-era aromatase inhibitors–including vorozole, letrozole, examestane, and anastrazole–elevated the survival time for sufferers with advanced breast cancers. They claim that aromatase inhibitors ought to be used as a short therapy for these individuals. ‘The meta-analysis offers solid evidence for the use of third-generation aromatase inhibitors and inactivators in the treatment of advanced breast cancer,’ the authors write. In an accompanying editorial, Daniel F. Hayes, M.D., and Catherine H. Van Poznak, M.D., of the University of Michigan Health insurance and Hospital Program in Ann Arbor, write, ‘We believe that this study was well executed and that the results are appropriate.The Queensland Authorities has ordered independent tests of the company’s wells and says it must find out where in fact the chemicals came from. Western Downs Regional Council Mayor Ray Dark brown feels it really is ethical that the company informed local and State Governments promptly.?.. BIOTONE donates $5,000 to Council of Community Treatment centers for breast cancer research BIOTONE announces a donation of $5,000 to the Council of Community Treatment centers to greatly help fund diagnostics meant for breast malignancy. The San Diego-structured Council of Community Treatment centers provides centralized support solutions to 16 member community clinic and health middle organizations operating nearly 100 sites in NORTH PARK, Imperial, and Riverside Counties in California.